An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

View Sample PDF

Author(s): Amar Gupta (The University of Arizona, USA), Ray Woosley (The Critical Path Institute, USA), Igor Crk (The University of Arizona, USA)and Surendra Sarnikar (The University of Arizona, USA)
Copyright: 2007
Volume: 2
Issue: 3
Pages: 16
Source title: International Journal of Healthcare Information Systems and Informatics (IJHISI)
Editor(s)-in-Chief: Qiang (Shawn) Cheng (University of Kentucky, USA)and Joseph Tan (McMaster University, Canada)
DOI: 10.4018/jhisi.2007070106

Keywords: Health Information Systems / Medical Information Science Reference / Medicine & Healthcare

Purchase

View An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance on the publisher's website for pricing and purchasing information.

Abstract

Adverse drug events impose a large cost on the society in terms of lives and health care costs. In this article, we propose an information technology architecture for enabling the monitoring of adverse drug events in an outpatient setting as a part of the post marketing surveillance program. The proposed system architecture enables the development of a Web-based drug effectiveness reporting and monitoring system that builds on previous studies demonstrating the feasibility of a system in which community pharmacists identify and report adverse drug events. We define the key technical requirements of such a monitoring and reporting system, identify the critical factors that influence the successful implementation and use of the system, and propose information technology solutions that satisfy these requirements.

The IRMA Community

Research IRM

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

Purchase

Abstract

Related Content

IRMA Sponsors